Brand

Par Pharmaceutical, Inc. Recalls

16 recalls on record. Search official CPSC, FDA, and USDA datasets for every recall issued for Par Pharmaceutical, Inc..

16Total Recalls
1Critical
2.6MUnits Affected
Aug 10, 2020Most Recent
All Recalls

Every Par Pharmaceutical, Inc. Recall

Sorted by most recent. Click any recall for full details.

16 recalls
High RiskFDA
Par Pharmaceutical Inc.
BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01
Oral Drugs·11,347 affected·Aug 10, 2020
High RiskFDA
Par Pharmaceutical Inc.
Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par...
Oral Drugs·29,352 affected·Mar 30, 2020
RecallFDA
Par Pharmaceutical Inc.
PrediniSONE Tablets, USP 5 mg, 48-count bottle, Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 0603-5337-31
Oral Drugs·13,008 affected·Mar 4, 2020
RecallFDA
Par Pharmaceutical Inc.
Frovatriptan Succinate Tablets, 2.5mg, packaged in 1 blister card of 9 tablets per carton, Rx Only, Manufactured by: Almac Pharma Service...
Oral Drugs·9,936 affected·Feb 10, 2020
CriticalFDA
Par Pharmaceutical, Inc.
Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 109...
Injectable Drugs·4,506 affected·Apr 30, 2019
RecallFDA
Par Pharmaceutical, Inc.
Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by: Par Pharmaceutical...
Oral Drugs·16,207 affected·Sep 6, 2018
High RiskFDA
Par Pharmaceutical, Inc.
Travoprost Ophthalmic Solution USP, 0.004%, a) 2.5 mL and b) 5 mL bottles, Rx only, FOR USE IN THE EYES ONLY, Made in India, Distributed ...
Ophthalmic Drugs·182,856 affected·Oct 5, 2016
Medium RiskFDA
Par Pharmaceutical, Inc.
Gildess FE 1/20 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0.02 mg, USP and ferrous fumarate tablets, USP 75 mg), 28 cou...
Oral Drugs·822,009 affected·Sep 27, 2016
RecallFDA
Par Pharmaceutical, Inc.
Gildess 24 FE 1.5/30 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0.02 mg, USP and ferrous fumarate tablets, USP 75 mg), 2...
Oral Drugs·44,127 affected·Sep 27, 2016
Medium RiskFDA
Par Pharmaceutical, Inc.
Gildess 1.5/30 (norethindrone acetate, 1.5 mg and ethinyl estradiol tablets, 0.03 mg, USP), 21 count, (a) 3 blisters (NDC 0603-7606-48) a...
Oral Drugs·221,017 affected·Sep 27, 2016
Medium RiskFDA
Par Pharmaceutical, Inc.
Gildess FE 1.5/30 (norethindrone acetate, 1.5 mg and ethinyl estradiol tablets, 0.03 mg, USP and ferrous fumarate tablets, USP 75 mg), 6 ...
Oral Drugs·278,406 affected·Sep 27, 2016
Medium RiskFDA
Par Pharmaceutical, Inc.
Gildess 1/20 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0,02 mg, USP), 21 count, (a) 3 blisters (NDC 0603-7607-48) and (...
Oral Drugs·393,981 affected·Sep 27, 2016
Medium RiskFDA
Par Pharmaceutical Inc.
Meclizine Hydrochloride Tablets USP, 25 mg Tablets, Packaged in a) 100 Ct Bottles (NDC: 49884-035-01) and b) 1000 Ct Bottles (NDC: 49884-...
Oral Drugs·387,100 affected·Oct 26, 2015
Medium RiskFDA
Par Pharmaceutical Inc.
Meclizine Hydrochloride Tablets, USP, 12.5 mg Tablets, Packaged in a) 100 Ct Bottles (NDC: 49884-034-01) and b) 1000 Ct Bottles (NDC: 498...
Oral Drugs·162,385 affected·Oct 26, 2015
High RiskFDA
Par Pharmaceutical Inc.
Mafenide Acetate, USP, For 5% Topical Solution, STERILE, Net Wt. 50 grams sterile powder per packet, Rx only, PAR Pharmaceuticals label -...
Topical Drugs·2,856 affected·Feb 12, 2015
High RiskFDA
Par Pharmaceutical Inc.
HydrALAZINE Hydrochloride Tablets, USP 25 mg, 100 count bottle Rx only, Distributed by: Par Pharmaceutical Companies, Inc. Spring Valley,...
Oral Drugs·38,788 affected·Nov 24, 2014